Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Seqirus
Pharma
CSL delays vax unit spinoff as US immunization rates plummet
CSL’s leaders said they expect this season's flu vaccination rates in the U.S. to decline by 12% overall compared with last year.
Eric Sagonowsky
Oct 28, 2025 10:00am
HHS signs off on recommendation to ban thimerosal from vaccines
Jul 23, 2025 3:03pm
CSL Seqirus picks up its 5th bird-flu-related BARDA award
Sep 26, 2024 3:50pm
Driving flu vaccine uptake in the post-pandemic era
Aug 30, 2024 8:00am
Europe taps CSL Seqirus to produce bird flu vaccines
Jun 11, 2024 4:20pm
UK enlists CSL Seqirus for flu pandemic vaccine preparedness
Sep 26, 2023 10:55am
